FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979969354> ?p ?o ?g. }

• W1979969354 endingPage "531" @default.
• W1979969354 startingPage "522" @default.
• W1979969354 abstract "The D2/D3 dopamine receptor agonist pramipexole, protects against toxin-induced dopaminergic neuronal destruction but its mechanism of action is unknown. Inflammation following glial cell activation contributes to cell death in Parkinson's disease and we now report on the effects of acute or chronic administration of pramipexole on lipopolysaccharide (LPS) induced inflammation and nigral dopaminergic cell death in the rat. At 48 h and 30 days following supranigral administration of LPS, approximately 70% of tyrosine hydroxylase (TH) immunoreactive (-ir) cells in substantia nigra had degenerated with a corresponding loss of TH-ir terminals in the striatum. In rats acutely treated with pramipexole (2 × 1 mg/kg; s.c.) 48 h following LPS application, there was no difference in the number of TH-ir cells or terminals compared to LPS-treated rats receiving vehicle. However, the continuous subcutaneous infusion of pramipexole for 7 days prior to LPS and 21 days subsequently, produced a marked preservation of both TH-ir cells and terminals. At 48 h or 30 days, LPS induced an up-regulation of ubiquitin-ir within the nigral TH-ir neurones, which was reduced by pramipexole treatment. Thirty days following supranigral LPS administration (9 days after the end of infusion), (+)-amphetamine (5 mg/kg, i.p.) caused robust ipsiversive rotation. In rats treated with LPS but receiving continuous subcutaneous administration of pramipexole, (+)-amphetamine-induced rotation was markedly reduced. LPS-induced increase in the levels of inflammatory markers, were not affected by either acute administration or continuous infusion of pramipexole. Continuous infusion of pramipexole protected dopaminergic neurones against inflammation induced degeneration but without modification of the inflammatory response." @default.
• W1979969354 created "2016-06-24" @default.
• W1979969354 creator A5013470252 @default.
• W1979969354 creator A5016584993 @default.
• W1979969354 creator A5022335418 @default.
• W1979969354 creator A5030909442 @default.
• W1979969354 creator A5038659593 @default.
• W1979969354 creator A5039883246 @default.
• W1979969354 creator A5044760872 @default.
• W1979969354 date "2008-08-01" @default.
• W1979969354 modified "2023-10-15" @default.
• W1979969354 title "Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response" @default.
• W1979969354 cites W1545110321 @default.
• W1979969354 cites W1933195856 @default.
• W1979969354 cites W19478429 @default.
• W1979969354 cites W1964463501 @default.
• W1979969354 cites W1972012028 @default.
• W1979969354 cites W1978406998 @default.
• W1979969354 cites W1994457469 @default.
• W1979969354 cites W1997887984 @default.
• W1979969354 cites W1999922500 @default.
• W1979969354 cites W2004536195 @default.
• W1979969354 cites W2012971273 @default.
• W1979969354 cites W2013616447 @default.
• W1979969354 cites W2019962808 @default.
• W1979969354 cites W2029973048 @default.
• W1979969354 cites W2038814798 @default.
• W1979969354 cites W2039190334 @default.
• W1979969354 cites W2046139547 @default.
• W1979969354 cites W2046174900 @default.
• W1979969354 cites W2046465340 @default.
• W1979969354 cites W2051981816 @default.
• W1979969354 cites W2055750901 @default.
• W1979969354 cites W2056546282 @default.
• W1979969354 cites W2058063216 @default.
• W1979969354 cites W2060460175 @default.
• W1979969354 cites W2062594350 @default.
• W1979969354 cites W2062781235 @default.
• W1979969354 cites W2066908355 @default.
• W1979969354 cites W2068800657 @default.
• W1979969354 cites W2071362963 @default.
• W1979969354 cites W2075541529 @default.
• W1979969354 cites W2077360634 @default.
• W1979969354 cites W2077821351 @default.
• W1979969354 cites W2079307348 @default.
• W1979969354 cites W2085872894 @default.
• W1979969354 cites W2086383166 @default.
• W1979969354 cites W2087541485 @default.
• W1979969354 cites W2107197030 @default.
• W1979969354 cites W2107403624 @default.
• W1979969354 cites W2109747317 @default.
• W1979969354 cites W2118825726 @default.
• W1979969354 cites W2130403851 @default.
• W1979969354 cites W2131112427 @default.
• W1979969354 cites W2135843341 @default.
• W1979969354 cites W2146008698 @default.
• W1979969354 cites W2148726772 @default.
• W1979969354 cites W2153187922 @default.
• W1979969354 cites W2158512964 @default.
• W1979969354 cites W2158905357 @default.
• W1979969354 cites W4239875825 @default.
• W1979969354 doi "https://doi.org/10.1016/j.expneurol.2008.04.037" @default.
• W1979969354 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18571649" @default.
• W1979969354 hasPublicationYear "2008" @default.
• W1979969354 type Work @default.
• W1979969354 sameAs 1979969354 @default.
• W1979969354 citedByCount "30" @default.
• W1979969354 countsByYear W19799693542012 @default.
• W1979969354 countsByYear W19799693542013 @default.
• W1979969354 countsByYear W19799693542014 @default.
• W1979969354 countsByYear W19799693542015 @default.
• W1979969354 countsByYear W19799693542016 @default.
• W1979969354 countsByYear W19799693542017 @default.
• W1979969354 countsByYear W19799693542018 @default.
• W1979969354 countsByYear W19799693542019 @default.
• W1979969354 countsByYear W19799693542020 @default.
• W1979969354 countsByYear W19799693542022 @default.
• W1979969354 countsByYear W19799693542023 @default.
• W1979969354 crossrefType "journal-article" @default.
• W1979969354 hasAuthorship W1979969354A5013470252 @default.
• W1979969354 hasAuthorship W1979969354A5016584993 @default.
• W1979969354 hasAuthorship W1979969354A5022335418 @default.
• W1979969354 hasAuthorship W1979969354A5030909442 @default.
• W1979969354 hasAuthorship W1979969354A5038659593 @default.
• W1979969354 hasAuthorship W1979969354A5039883246 @default.
• W1979969354 hasAuthorship W1979969354A5044760872 @default.
• W1979969354 hasConcept C126322002 @default.
• W1979969354 hasConcept C134018914 @default.
• W1979969354 hasConcept C137183658 @default.
• W1979969354 hasConcept C170493617 @default.
• W1979969354 hasConcept C2778938600 @default.
• W1979969354 hasConcept C2779134260 @default.
• W1979969354 hasConcept C2779734285 @default.
• W1979969354 hasConcept C2779989193 @default.
• W1979969354 hasConcept C2780938664 @default.
• W1979969354 hasConcept C513476851 @default.
• W1979969354 hasConcept C71924100 @default.
• W1979969354 hasConcept C98274493 @default.

• next